Pharmacotherapy Review 2022: Oncologic Disorders
Pharmacotherapy Review 2022: Oncologic Disorders is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.
Published: June 10, 2022
Expires: June 10, 2025
Goal:
To educate pharmacists about selected important advancements during 2021 in the treatment of patients with cancer.
Educational Objectives:
Upon completion of this program, participants should be better able to:
• Identify new oncologic drugs and indications that were approved in 2021
• Discuss the advancements of immune checkpoint inhibitors, personalized medicine, and their combination as well as updates in the treatment of non-small-cell lung cancer and renal cell carcinoma in 2021
• Recognize the implications of oncology biosimilars on formulary development and practice decisions
• Formulate COVID-19 vaccination recommendations for patients with cancer
Additional details will be posted as soon as information is available.